Return to Main Site 617-919-3019
401 Park Drive, 7th Floor East, Boston, MA 02215

TIDO Technology Search



Invention Type

Diagnostic/Prognostic
Information Technology/Software
Medical Device
Other
Research Tool
Therapeutics

Research Area

Allergy/Respiratory/Pulmonary Disease
Anesthesia
Audiology
Cardiovascular/Cardiology
Degenerative Disease
Dermatology
Endocrinology
Gastrointestinal/Nutrition
Genetic Disease
Health Care Management
Immunology
Infectious Disease
Inflammation
Internal Medicine
Metabolic Disease
Musculoskeletal
Neonatology/Pediatric
Neurology/Neuroscience
Oncology/Hematology
Ophthalmology
Orthopedics
Otolaryngology/Audiology
Pain
Pathology
Personalized Medicine
Psychiatric Disease
Radiology
Regenerative Medicine
Reproduction/Ob-Gyn
Stem Cell
Surgery/Wound Healing
Urology
CMCC 1134

Ubiquitin Proteasome Inhibitors to Prevent Axon Degeneration

Inventors: Zhigang He, Zhai Qiwei, Jing Wang, Liqun Luo, Ryan Watts, Eric Hoopfer

Invention Types: Therapeutics

Research Areas: Neurology/Neuroscience

Keywords: Disease Model, Drug Screening, Small Molecule/Drug

For More Information Contact:  Caron, Connie

 

Invention Description:

Invention demonstrates that specific compounds that either inhibit the ubiquitin proteasome pathway or stabilize microtubules can delay axon degeneration and promote neuronal regeneration. It includes (i) Methods and compounds for delaying axonal degeneration in pathological conditions; (ii) Specific and multiple compounds that can be used as therapeutics for degenerative neuropathies or neuronal diseases of the central nervous system, as demonstrated in multiple rodent models for disorders such as ischemia, Huntington's disease or ALS; (iii) Same compounds as in (ii) could be used for therapeutics to promote neuronal regeneration, as indicated in traumatized rats.

Applications:

Drug Development

Screening

Competitive Advantages:

Previous strategies designed to prevent neuronal cell death have resulted in limited success as therapies for neurodegeneration. It is likely that axon degeneration provides an early target for neurodegenerative disorders, as the methods and compounds provided in this technology suggest a delay in axon degeneration and disease progression.

Business Opportunity:

Exclusive License or Partnership for Development

Key Publications: Zhai et al. Neuron, Vol. 39, 217-225, July 17, 2003.

IPStatus: Abandoned